FMR LLC 13D and 13G filings for Lexicon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 10:32 am Purchase | 2024-11-08 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | FMR LLC | 49,867,042 13.794% | 11,179,919 (+28.90%) | Filing |
| 2024-07-10 10:10 am Purchase | 2024-07-09 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | FMR LLC | 38,687,123 10.702% | 33,018,985 (+582.54%) | Filing |
| 2022-02-09 09:22 am Sale | 2022-02-08 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | FMR LLC | 5,668,138 3.806% | -2,629,962 (-31.69%) | Filing |
| 2021-01-11 10:51 am Sale | 2021-01-08 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | FMR LLC | 8,298,100 5.864% | -4,261,394 (-33.93%) | Filing |
| 2020-02-07 11:24 am Sale | 2020-02-06 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | FMR LLC | 12,559,494 11.818% | -2,180,120 (-14.79%) | Filing |